Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers

NCT00969553 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim